恒指午後升幅扩至逾400点曾越百天线 腾讯/小米/药明生物涨4.5%-6% 安踏再破顶
沪深股市今天跑赢区内,其中沪指及深成午後升幅扩至2.2%及2.1%,分别报3,573及14,809。恒指午後升幅扩大曾重越百天线(28,841),最高见28,847,现造28,819,升407点或1.4%,成交额1,012亿元。
55只蓝筹几乎全部造好,药明生物(02269.HK)升幅扩至6%报116.4元。明天公布季绩兼获重新纳入富时全球股票指数系列的小米(01810.HK)午後升幅扩至5%,报28元,股价升破百天线(27.48元)。季绩逊预期连吐两天後的腾讯(00700.HK)重越10天及20天线,午後高见613元,现造612元,回升4.5%。舜宇(02382.HK)七连升,午後高见190.5元,暂受制百天线(191.9元),现造188.7元,续升3.6%。
内需股安踏(02020.HK)四连升,今天升破2月所创上市高位154.3元,午後最高见156.5元,现造156.3元,续升3.6%。蒙牛(02319.HK)、吉利(00175.HK)及百威亚太(01876.HK)也升逾2%,前者股价重越百天线(45.08元)曾高见45.7元,後者股价升破10天线(26.6)曾高见27.05元。
金融股以港交所(00388.HK)、中国平安(02318.HK)及国寿(02628.HK)表现最好,前者股价重越20天及50天线(462.3元),最高见468.4元,现造466元,回升3.5%;後两者回升2%及续升2.4%,股价分别重越20天线及重越百天线(16.4元),报82.9元及16.42元。
不过,上季多赚逾1倍的中生(01177.HK)续升至9.69元创逾九个月高遇阻,掉头倒跌2.8%曾低见8.65元。创科(00669.HK)、龙湖(00960.HK)及再探顶倒跌石药(01093.HK)也反覆跌不足1%。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.